HOME >> BIOLOGY >> NEWS
NIH panel outlines strategies for managing tumors of the adrenal glands

A panel convened by the National Institutes of Health issued recommendations to help physicians evaluate a particular class of tumors of the adrenal glands and determine which should be removed and which should be left alone. The tumors are known as "incidentalomas" because they are discovered by chance, as a result of testing for other conditions. Before the advent of sophisticated new imaging technologies, the tumors typically went undetected.

"Incidentalomas present a dilemma for physicians because while many of these masses are harmless, a few can progress into very serious conditions and cause a variety of complications," said panel chair Melvin Grumbach, M.D., Edwin B. Shaw Professor of Pediatrics Emeritus at the University of California in San Francisco. Noting that the prevalence of incidentalomas increases with age, Dr. Grumbach added that "the appropriate management of incidentalomas promises to be an increasingly common challenge for our aging society."

The adrenals are triangular glands that sit atop each kidney. They influence or regulate the body's metabolism, salt and water balance, response to stress, and other important functions by secreting a variety of hormones. Adrenal gland masses are among the most common tumors in humans, and although most cause no symptoms or health problems, a small proportion can lead to serious diseases, and approximately one out of every 4,000 adrenal masses is cancerous.

One type of adrenal tumor, known as a pheochromocytoma, releases hormones that can cause dangerously high blood pressure. Another type, known as an adrenal cortical cancer, has a high mortality rate. The panel recommends surgically removing both types when technically possible, regardless of size.

The panel members concurred with the prevailing view that incidentalomas should be surgically removed if they are greater than 6 cm, and that those under 4 cm, in some circumstances, may be followed to see if they grow
'"/>

Contact: Kelli Marciel
marcielk@od.nih.gov
301-496-4819
NIH/Office of the Director
6-Feb-2002


Page: 1 2 3

Related biology news :

1. AAAS expert panel calls for voter-system research and reform
2. Ecologist calls for creation of an international panel to assess human behavior
3. Hydrogen Initiative report from American Physical Society panel released
4. Parenting ethics panel explores thorny issues posed by technology
5. NIH consensus panel confirms effectiveness of total knee replacement
6. InterAcademy panel holds general assembly in Mexico
7. NY panel to discuss bioterrorism and medical issues
8. Advisory panel on federal report on carcinogens makes recommendations to NIEHS/NTP for new listings
9. Experts say independent scientific panels useful in advising judges in complex cases
10. In public session: panel to evaluate plasticizers for possible reproductive, developmental risks
11. Science panel endorses new non-animal test to see if chemicals will burn, corrode skin and eyes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... (PRWEB) , ... July 30, 2020 , ... ... prescription digital therapeutics product portfolio with a near term focus on Type 2 ... and pharma commercialization experience across multiple therapeutic areas and classes. As Chief Commercial ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate ... reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators ...
(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues ... An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, ... the most effective way to complete one? Will the study comply with all ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... HONG KONG (PRWEB) , ... July 09, 2020 ... ... chemical compound called 1-phenyl-2-thiourea (PTU) is commonly used to suppress pigment formation in ... years, the PolyU research team led by Dr MA has been using the ...
(Date:7/7/2020)... , ... July 06, 2020 , ... ... Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts ... Bio-IT World has hosted an elite awards program, highlighting outstanding examples of how ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... today announced that the launch of a new clinical diagnostics immuno-oncology ... the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that aids ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... today announced the company has entered a license agreement with Roswell Park Comprehensive ... globally exclusive rights to Roswell Park intellectual property surrounding a novel medical device ...
Breaking Biology Technology:
Cached News: